Angie Pittser Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 24400 State Highway 39, Shell Knob, MO 65747 Phone: 417-699-4517 |
News Archive
Today the New England Journal of Medicine published the first results of a phase III international clinical study called TITAN (National Clinical Trials Number 02489318), which evaluated the effectiveness and safety of a new drug, apalutamide, to treat advanced prostate cancers.
Exelixis, Inc. today announced that it has regained full rights to develop and commercialize XL184. Exelixis and Bristol-Myers Squibb Company entered into a global development collaboration for XL184, the clinically most advanced MET inhibitor, in December 2008. Under the agreement, BMS and Exelixis had originally agreed to certain clinical development plans, and Exelixis maintained key rights regarding timing and funding of current and future clinical trials.
Wolters Kluwer Health, a leading global provider of information for healthcare professionals and students, recently hosted a webinar examining the role of clinical decision support (CDS) technology in improving patient safety and outcomes in the acute, primary and emergency care settings.
The British chocolate giant Cadbury has become the latest victim in China's poisoned milk scandal - the company has reported finding melamine in its Chinese-made chocolates.
Many people suffer from pain when they fly but that may soon be a thing of the past. A new study from Aalborg University may have discovered the mechanisms responsible, opening the door to developing a cure.
› Verified 3 days ago